Soleno Therapeutics Financial Overview
Soleno Therapeutics's market cap is currently $2.66B. The company's EPS TTM is $0.47; its P/E ratio is -26.74; Soleno Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.62. See an overview of income statement, balance sheet, and cash flow financials.
